Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...
With certain government data currently being withheld, removed, or restored but partially redacted on the websites of the U.S ...
The American Cancer Society estimates for cancer of the uterus in the United States for 2025 are: About 69,120 new cases of cancer of the uterus will be diagnosed. About 13,860 women will die from ...
Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...
Verywell Health on MSN9d
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer TypeFact checked by Nick Blackmer The Food and Drug Administration (FDA) recently approved a new targeted chemotherapy drug for ...
Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase III trial results which ...
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of ...
The FY2024 revenue forecast remains unchanged, despite delays in approvals for Datroway in the lung cancer field ... offset Datroway’s shortfall. Daiichi Sankyo’s Q3 FY2024 results reflect ...
Japanese drugmaker Daiichi Sankyo (TYO: 4568) has appointed Hiroyuki Okuzawa to ... and Datroway (partnered with the UK’s AstraZeneca [LSE: AZN]), two precision cancer medicines invented with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback